These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3530205)
21. [Immunohistochemistry in the diagnosis and treatment of breast cancer]. Matsuura N; Ohnishi A; Itoh Y; Wakasugi E; Tsujimoto M Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():24-9. PubMed ID: 8702307 [TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
23. Future prospects for the staging of breast cancer. Rutgers EJ; Peterse HL Semin Surg Oncol; 1996; 12(1):3-11. PubMed ID: 8821404 [TBL] [Abstract][Full Text] [Related]
24. Aromatase in the context of breast and endometrial cancer. A review. Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363 [TBL] [Abstract][Full Text] [Related]
25. [Comparative study between carcinoembryonic antigen (CEA) in breast cancer tissue and morphological regional immunoreaction: preliminary report]. Asagoe T; Yamoto H; Hanatani Y; Horie H; Nemoto A; Kidooka K; Shikata J Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):534. PubMed ID: 2198457 [No Abstract] [Full Text] [Related]
26. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346 [TBL] [Abstract][Full Text] [Related]
27. [Prognostic-predictive factors and therapeutic choices in invasive carcinoma of the breast]. Puglisi F; Di Loreto C; Beltrami CA Ann Ital Chir; 1999; 70(3):335-41. PubMed ID: 10466235 [TBL] [Abstract][Full Text] [Related]
28. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Masood S Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901 [TBL] [Abstract][Full Text] [Related]
29. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor determination in human breast cancer. Parl FF Prog Clin Pathol; 1984; 9():155-72. PubMed ID: 6364221 [No Abstract] [Full Text] [Related]
31. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867 [TBL] [Abstract][Full Text] [Related]
32. [Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status]. Vogel J; Oehr P; Totović V; Bellmann O; Dworak O Verh Dtsch Ges Pathol; 1985; 69():226-31. PubMed ID: 3913197 [No Abstract] [Full Text] [Related]
33. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Shekhar MP; Werdell J; Tait L Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599 [TBL] [Abstract][Full Text] [Related]
34. Role of preoperative plasma CA 15-3 and carcinoembryonic antigen levels in determining histopathologic conventional prognostic factors for breast cancer. Seker D; Kaya O; Adabag A; Necipoglu G; Baran I World J Surg; 2003 May; 27(5):519-21. PubMed ID: 12715215 [TBL] [Abstract][Full Text] [Related]
35. [Biological features of breast cancer in patients under 35]. Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136 [TBL] [Abstract][Full Text] [Related]
36. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556 [TBL] [Abstract][Full Text] [Related]
37. Association of age and reproductive factors with benign breast tissue composition. Gertig DM; Stillman IE; Byrne C; Spiegelman D; Schnitt SJ; Connolly JL; Colditz GA; Hunter DJ Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):873-9. PubMed ID: 10548315 [TBL] [Abstract][Full Text] [Related]
38. Polyamines in human breast cancer and its relations to classical prognostic features: clinical implications. Leveque J; Bansard JY; Watier E; Catros-Quemener V; Havouis R; Moulinoux JP; Grall JY; Seiler N Anticancer Res; 1999; 19(3B):2275-9. PubMed ID: 10472343 [TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in breast carcinoma. Weidner N Curr Opin Obstet Gynecol; 1995 Feb; 7(1):4-9. PubMed ID: 7742514 [TBL] [Abstract][Full Text] [Related]
40. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. Pasqualini JR; Chetrite GS J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]